Englander Zoë A, Sun Jessica, Mikati Mohamad A, Kurtzberg Joanne, Song Allen W
Brain Imaging and Analysis Center, Duke University Medical Center, United States ; Department of Biomedical Engineering, Duke University Medical Center, United States.
Department of Pediatrics, Duke University Medical Center, United States ; The Robertson Cell and Translational Therapy Center, Duke University Medical Center, United States.
Neuroimage Clin. 2015 Jan 9;7:315-24. doi: 10.1016/j.nicl.2015.01.002. eCollection 2015.
Cerebral Palsy (CP) refers to a heterogeneous group of permanent but non-progressive movement disorders caused by injury to the developing fetal or infant brain (Bax et al., 2005). Because of its serious long-term consequences, effective interventions that can help improve motor function, independence, and quality of life are critically needed. Our ongoing longitudinal clinical trial to treat children with CP is specifically designed to meet this challenge. To maximize the potential for functional improvement, all children in this trial received autologous cord blood transfusions (with order randomized with a placebo administration over 2 years) in conjunction with more standard physical and occupational therapies. As a part of this trial, magnetic resonance imaging (MRI) is used to improve our understanding of how these interventions affect brain development, and to develop biomarkers of treatment efficacy. In this report, diffusion tensor imaging (DTI) and subsequent brain connectome analyses were performed in a subset of children enrolled in the clinical trial (n = 17), who all exhibited positive but varying degrees of functional improvement over the first 2-year period of the study. Strong correlations between increases in white matter (WM) connectivity and functional improvement were demonstrated; however no significant relationships between either of these factors with the age of the child at time of enrollment were identified. Thus, our data indicate that increases in brain connectivity reflect improved functional abilities in children with CP. In future work, this potential biomarker can be used to help differentiate the underlying mechanisms of functional improvement, as well as to identify treatments that can best facilitate functional improvement upon un-blinding of the timing of autologous cord blood transfusions at the completion of this study.
脑性瘫痪(CP)是指因胎儿或婴儿发育中的大脑受到损伤而导致的一组异质性永久性非进行性运动障碍(Bax等人,2005年)。由于其严重的长期后果,迫切需要有效的干预措施来帮助改善运动功能、独立性和生活质量。我们正在进行的治疗脑性瘫痪儿童的纵向临床试验专门设计用于应对这一挑战。为了最大限度地提高功能改善的潜力,该试验中的所有儿童都接受了自体脐带血输血(顺序随机,在2年时间内与安慰剂给药交替进行),并结合了更标准的物理和职业治疗。作为该试验的一部分,磁共振成像(MRI)被用于增进我们对这些干预措施如何影响大脑发育的理解,并开发治疗效果的生物标志物。在本报告中,对参与该临床试验的一部分儿童(n = 17)进行了扩散张量成像(DTI)及后续的脑连接组分析,这些儿童在研究的头两年期间均表现出积极但程度不同的功能改善。结果表明白质(WM)连接性增加与功能改善之间存在强相关性;然而,未发现这些因素中的任何一个与入组时儿童年龄之间存在显著关系。因此,我们的数据表明,大脑连接性的增加反映了脑性瘫痪儿童功能能力的改善。在未来的工作中,这种潜在的生物标志物可用于帮助区分功能改善的潜在机制,以及在本研究完成后自体脐带血输血时间揭晓时,识别最能促进功能改善的治疗方法。